The genotype of RAET1L (ULBP6), a ligand for human NKG2D (KLRK1), markedly influences the clinical outcome of allogeneic stem cell transplantation

British Journal of Haematology

Volumn 159, Issue 5, 2012, Pages 589-598

  Antoun, Ayman ^a   Vekaria, Dhruti ^a   Salama, Rafik A ^b   Pratt, Guy ^a,c   Jobson, Shirley ^d   Cook, Mark ^e   Briggs, David ^d   Moss, Paul ^a,e  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^d NHS BLOOD AND TRANSPLANT   (United Kingdom)

^e UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Alleles; NKG2D ligands; Polymorphism; RAET1L; Transplantation

Indexed keywords

ALEMTUZUMAB; BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; ETOPOSIDE; FLUDARABINE; MELPHALAN; METHOTREXATE; NATURAL KILLER CELL RECEPTOR NKG2D; RAET1L PROTEIN; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ALLELE; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CHILD; CONTROLLED STUDY; DONOR; FEMALE; GENE; GENOTYPE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNE RESPONSE; INFANT; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAET1 GENE; RAET1L GENE; RECURRENCE FREE SURVIVAL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; GENOTYPE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; INFANT, NEWBORN; LEUKEMIA; LIGANDS; LYMPHOMA, NON-HODGKIN; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84869090195     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12072     Document Type: Article

References (44)

1. Aalen, O. (1978) Non parametric estimation of partial transition probabilities in multiple decrement models. Annals of Statistics, 6, 534-545.
2. Agresti, A. (2002) Categorial Data Analysis. Wiley, New York, NY.
3. Antoun, A., Jobson, S., Cook, M., Moss, P. & Briggs, D. (2009) Ethnic variability in human leukocyte antigen-E haplotypes. Tissue Antigens, 73, 39-45.
4. Antoun, A., Jobson, S., Cook, M., O'Callaghan, C.A., Moss, P. & Briggs, D.C. (2010) Single nucleotide polymorphism analysis of the NKG2D ligand cluster on the long arm of chromosome 6: extensive polymorphisms and evidence of diversity between human populations. Human Immunology, 71, 610-620.
5. Benjamin, J.E., Gill, S. & Negrin, R.S. (2010) Biology and clinical effects of natural killer cells in allogeneic transplantation. Current Opinion in Oncology, 22, 130-137.
6. Benjamini, Y. & Hochberg, Y. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society. Series B (Methodological), 57, 289-300.
7. Bleakley, M. & Riddell, S.R. (2004) Molecules and mechanisms of the graft-versus-leukaemia effect. Nature Reviews Cancer, 4, 371-380.
8. Boukouaci, W., Busson, M., Peffault de Latour, R., Rocha, V., Suberbielle, C., Bengoufa, D., Dulphy, N., Haas, P., Scieux, C., Amroun, H., Gluckman, E., Krishnamoorthy, R., Toubert, A., Charron, D., Socie, G. & Tamouza, R. (2009) MICA-129 genotype, soluble MICA, and anti-MICA antibodies as biomarkers of chronic graft-versus-host disease. Blood, 114, 5216-5224.
9. Burgess, S.J., Maasho, K., Masilamani, M., Narayanan, S., Borrego, F. & Coligan, J.E. (2008) The NKG2D receptor: immunobiology and clinical implications. Immunologic Research, 40, 18-34.
10. Cao, W., Xi, X., Hao, Z., Li, W., Kong, Y., Cui, L., Ma, C., Ba, D. & He, W. (2007) RAET1E2, a soluble isoform of the UL16-binding protein RAET1E produced by tumor cells, inhibits NKG2D-mediated NK cytotoxicity. The Journal of Biological Chemistry, 282, 18922-18928.
11. Castriconi, R., Cantoni, C., Della Chiesa, M., Vitale, M., Marcenaro, E., Conte, R., Biassoni, R., Bottino, C., Moretta, L. & Moretta, A. (2003) Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells. Proceedings of the National Academy of Sciences of the United States of America, 100, 4120-4125.
12. Cook, M.A., Moss, P.A. & Briggs, D.C. (2003) The distribution of 13 killer-cell immunoglobulin-like receptor loci in UK blood donors from three ethnic groups. European Journal of Immunogenetics, 30, 213-221.
13. Cosman, D., Mullberg, J., Sutherland, C.L., Chin, W., Armitage, R., Fanslow, W., Kubin, M. & Chalupny, N.J. (2001) ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity, 14, 123-133.
14. Crocchiolo, R., Zino, E., Vago, L., Oneto, R., Bruno, B., Pollichieni, S., Sacchi, N., Sormani, M.P., Marcon, J., Lamparelli, T., Fanin, R., Garbarino, L., Miotti, V., Bandini, G., Bosi, A., Ciceri, F., Bacigalupo, A. & Fleischhauer, K. (2009) Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation. Blood, 114, 1437-1444.
15. Eagle, R.A. & Trowsdale, J. (2007) Promiscuity and the single receptor: NKG2D. Nature Reviews Immunology, 7, 737-744.
16. Eagle, R.A., Traherne, J.A., Hair, J.R., Jafferji, I. & Trowsdale, J. (2009) ULBP6/RAET1L is an additional human NKG2D ligand. European Journal of Immunology, 39, 3207-3216.
17. Eleme, K., Taner, S.B., Onfelt, B., Collinson, L.M., McCann, F.E., Chalupny, N.J., Cosman, D., Hopkins, C., Magee, A.I. & Davis, D.M. (2004) Cell surface organization of stress-inducible proteins ULBP and MICA that stimulate human NK cells and T cells via NKG2D. The Journal of Experimental Medicine, 199, 1005-1010.
18. Excoffier, L., Laval, G. & Schneider, S. (2005) Arlequin (version 3.0): an integrated software package for population genetics data analysis. Evolutionary Bioinformatics Online, 1, 47-50.
19. Grambsch, P. & Therneau, T. (1994) Proportional hazards tests and diagnostics based on weighted residuals. Biometrika, 81, 515-526.
20. Gray, R.J. (1988) A class of K-sample tests for comparing the cumulative incidence of a competing risk. Annals of Statistics, 16, 1141-1154.
21. Guan, H., Moretto, M., Bzik, D.J., Gigley, J. & Khan, I.A. (2007) NK cells enhance dendritic cell response against parasite antigens via NKG2D pathway. The Journal of Immunology, 179, 590-596.
22. Harrington, D. & Fleming, T. (1982) A class of rank test procedures for censored survival data. Biometrika, 69, 553-566.
23. Hastie, T.J. & Pregibon, D. (1992) Generalized linear models. In: Statistical Models in S (eds. by Chambers, J.M., Hastie, T.J.), pp. 195-248. Wadsworth & Brooks/Cole Advanced Books & Software, Monterey, CA.
24. Hertz-Picciotto, I. & Rockhill, B. (1997) Validity and efficiency of approximation methods for tied survival times in Cox regression. Biometrics, 53, 1151-1156.
25. Hoogendoorn, B., Coleman, S.L., Guy, C.A., Smith, K., Bowen, T., Buckland, P.R. & O'Donovan, M.C. (2003) Functional analysis of human promoter polymorphisms. Human Molecular Genetics, 12, 2249-2254.
26. Hubbard, T.J., Aken, B.L., Beal, K., Ballester, B., Caccamo, M., Chen, Y., Clarke, L., Coates, G., Cunningham, F., Cutts, T., Down, T., Dyer, S.C., Fitzgerald, S., Fernandez-Banet, J., Graf, S., Haider, S., Hammond, M., Herrero, J., Holland, R., Howe, K., Johnson, N., Kahari, A., Keefe, D., Kokocinski, F., Kulesha, E., Lawson, D., Longden, I., Melsopp, C., Megy, K., Meidl, P., Ouverdin, B., Parker, A., Prlic, A., Rice, S., Rios, D., Schuster, M., Sealy, I., Severin, J., Slater, G., Smedley, D., Spudich, G., Trevanion, S., Vilella, A., Vogel, J., White, S., Wood, M., Cox, T., Curwen, V., Durbin, R., Fernandez-Suarez, X.M., Flicek, P., Kasprzyk, A., Proctor, G., Searle, S., Smith, J., Ureta-Vidal, A. & Birney, E. (2007) Ensembl 2007. Nucleic Acids Research, 35, D610-D617.
27. Klein, J.P., Rizzo, J.D., Zhang, M.J. & Keiding, N. (2001a) Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: regression modeling. Bone Marrow Transplantation, 28, 1001-1011.
28. Klein, J.P., Rizzo, J.D., Zhang, M.J. & Keiding, N. (2001b) Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: unadjusted analysis. Bone Marrow Transplantation, 28, 909-915.
29. Kolb, H.J. (2008) Graft-versus-leukemia effects of transplantation and donor lymphocytes. Blood, 112, 4371-4383.
30. Lanier, L.L. (2008) Up on the tightrope: natural killer cell activation and inhibition. Nature Immunology, 9, 495-502.
31. Lee, J.C., Lee, K.M., Kim, D.W. & Heo, D.S. (2004) Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients. The Journal of Immunology, 172, 7335-7340.
32. McQuarrie, A.D.R. & Tsai, C.L. (1998) Regression and Time Series Model Selection. World Scientific, River Edge, NJ.
33. Pende, D., Rivera, P., Marcenaro, S., Chang, C.C., Biassoni, R., Conte, R., Kubin, M., Cosman, D., Ferrone, S., Moretta, L. & Moretta, A. (2002) Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity. Cancer Research, 62, 6178-6186.
34. R Development Core Team (2011) R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria.
35. Radosavljevic, M., Cuillerier, B., Wilson, M.J., Clement, O., Wicker, S., Gilfillan, S., Beck, S., Trowsdale, J. & Bahram, S. (2002) A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3. Genomics, 79, 114-123.
36. Ringden, O., Karlsson, H., Olsson, R., Omazic, B. & Uhlin, M. (2009) The allogeneic graft-versus-cancer effect. British Journal of Haematology, 147, 614-633.
37. Rodriguez-Rodero, S., Gonzalez, S., Rodrigo, L., Fernandez-Morera, J.L., Martinez-Borra, J., Lopez-Vazquez, A. & Lopez-Larrea, C. (2007) Transcriptional regulation of MICA and MICB: a novel polymorphism in MICB promoter alters transcriptional regulation by Sp1. European Journal of Immunology, 37, 1938-1953.
38. Shlomchik, W.D., Couzens, M.S., Tang, C.B., McNiff, J., Robert, M.E., Liu, J., Shlomchik, M.J. & Emerson, S.G. (1999) Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science, 285, 412-415.
39. Spies, T. (2008) Regulation of NKG2D ligands: a purposeful but delicate affair. Nature Immunology, 9, 1013-1015.
40. Therneau, T. & Grambsch, P. (2000) Modeling Survival Data: Extending the Cox Model. Springer-Verlag, New York, NY.
41. Toubai, T., Sun, Y. & Reddy, P. (2008) GVHD pathophysiology: is acute different from chronic? Best Practice and Research. Clinical Haematology, 21, 101-117.
42. Valiante, N.M., Lienert, K., Shilling, H.G., Smits, B.J. & Parham, P. (1997) Killer cell receptors: keeping pace with MHC class I evolution. Immunological Reviews, 155, 155-164.
43. Venables, W.N. & Ripley, B.D. (2002) Modern Applied Statistics with S. Springer, New York, NY.
44. Waldhauer, I. & Steinle, A. (2006) Proteolytic release of soluble UL16-binding protein 2 from tumor cells. Cancer Research, 66, 2520-2526.